Horizon Kinetics Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Sell |
13,792
-804
| -6% | -$7.54K | ﹤0.01% | 324 |
|
|
2025
Q1 | $104K | Buy |
14,596
+200
| +1% | +$1.42K | ﹤0.01% | 322 |
|
|
2024
Q4 | $168K | Buy |
14,396
+604
| +4% | +$7.04K | ﹤0.01% | 316 |
|
|
2024
Q3 | $283K | Sell |
13,792
-604
| -4% | -$12.4K | ﹤0.01% | 279 |
|
|
2024
Q2 | $322K | Hold |
14,396
| – | – | 0.01% | 246 |
|
|
2024
Q1 | $396K | Hold |
14,396
| – | – | 0.01% | 229 |
|
|
2023
Q4 | $439K | Sell |
14,396
-604
| -4% | -$18.4K | 0.01% | 214 |
|
|
2023
Q3 | $474K | Hold |
15,000
| – | – | 0.01% | 216 |
|
|
2023
Q2 | $612K | Hold |
15,000
| – | – | 0.01% | 196 |
|
|
2023
Q1 | $559K | Buy |
15,000
+5,000
| +50% | +$186K | 0.01% | 205 |
|
|
2022
Q4 | $349K | Hold |
10,000
| – | – | 0.01% | 238 |
|
|
2022
Q3 | $560K | Hold |
10,000
| – | – | 0.01% | 200 |
|
|
2022
Q2 | $518K | Hold |
10,000
| – | – | 0.01% | 207 |
|
|
2022
Q1 | $727K | Hold |
10,000
| – | – | 0.01% | 200 |
|
|
2021
Q4 | $1.18M | Hold |
10,000
| – | – | 0.03% | 165 |
|
|
2021
Q3 | $1.34M | Hold |
10,000
| – | – | 0.03% | 149 |
|
|
2021
Q2 | $1.62M | Hold |
10,000
| – | – | 0.03% | 143 |
|
|
2021
Q1 | $803K | Hold |
10,000
| – | – | 0.02% | 196 |
|
|
2020
Q4 | $544K | Hold |
10,000
| – | – | 0.02% | 223 |
|
|
2020
Q3 | $199K | Hold |
10,000
| – | – | 0.01% | 332 |
|
|
2020
Q2 | $210K | Buy |
+10,000
| New | +$210K | 0.01% | 334 |
|